AstraZeneca
(https://onglyza.com) 📸 Data Snapshot: May 31, 2026Pull the main entities out of the H1, then check whether they actually recur through the body. A page that announces one thing and then talks about another drifts. Headings with no real sentences underneath read as pseudo-substance.
There is zero semantic drift across the analyzed pages. The homepage H1 AstraZeneca medications perfectly aligns with the content of all sub-pages, which function as identical lists of the company’s pharmaceutical portfolio. The hero section makes no breakthrough claims that are not immediately supported by links to clinical Prescribing Information. The target audience remains consistently split between US residents, healthcare professionals, and patients across all page iterations.
Semantic Coherence is read from the heading hierarchy first: what each page announces in its H1 and headings, then whether the body actually delivers on it. Below is the structure the engine mapped, followed by the clean text to check for drift between promise and reality.
🏗️ Semantic Structure — heading hierarchy & page identity (the promise the page makes)
HOMEPAGE AstraZeneca Medications (https://onglyza.com)
AstraZeneca Medications
NAV_HEADING_REPEATED_BODY_FOOTER AstraZeneca Medications (https://onglyza.com/medicines/Affordability.html)
AstraZeneca Medications
NAV_HEADING_REPEATED_FOOTER AstraZeneca Medications (https://onglyza.com/az-in-us.html)
AstraZeneca Medications
NAV_HEADING_REPEATED_FOOTER AstraZeneca Medications (https://onglyza.com/medicines/astrazeneca-medications.html)
AstraZeneca Medications
📝 The Narrative — clean text per page (homepage promise vs. sub-page reality)
HOMEPAGE (https://onglyza.com) AstraZeneca Medications
[H2] The list below contains full Prescribing Information for all of our medicines and a range of websites dedicated to providing you with product-specific information. The information contained below is intended for US residents only. In order to monitor the safety of AstraZeneca products, we encourage reporting any side effects experienced while taking an AstraZeneca product to the AZ Information Center at 1-800-236-9933. Alternatively, you can report any side effects of prescription drugs directly to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088. [H2] Help affording your medicines We believe it’s not enough for us to simply make medicines. We have to make sure that the people who need those medicines can get them. Learn more [H3] AIRSUPRA™ (albuterol/budesonide) Prescribing Information Consumer site Health care professional site [H3] ANDEXXA® Coagulation Factor Xa (recombinant), inactivated-zhzo Prescribing Information Consumer site Health care professional site [H3] BAXFENDY® (baxdrostat) Tablets Prescribing Information Consumer site Health care professional site [H3] BEVESPI AEROSPHERE® (glycopyrrolate and formoterol fumarate) Inhalation Aerosol Prescribing Information Consumer site [H3] BREZTRI AEROSPHERE® (budesonide, glycopyrrolate, and formoterol fumarate) Inhalation Aerosol Prescribing Information Consumer site Health care professional site [H3] BRILINTA® (ticagrelor) tablets Prescribing Information including Boxed WARNINGS Consumer site Health care professional site [H3] BYDUREON BCise® (exenatide extended-release) injectable suspension Prescribing Information including Boxed WARNING [H3] BYETTA® (exenatide) injection Prescribing Information [H3] CALQUENCE® (acalabrutinib) tablets Prescribing Information Consumer site Health care professional site [H3] CRESTOR® (rosuvastatin) Tablets Prescribing Information Consumer site Health care professional site [H3] DALIRESP® (roflumilast) tablets Prescribing Information Consumer site Health care professional site [H3] ENHERTU® (fam-trastuzumab deruxtecan-nxki) injection for intravenous use Prescribing Information including Boxed WARNING Health care professional site [H3] EPANOVA® (omega-3-carboxylic acids) Capsules Prescribing Information [H3] FARXIGA® (dapagliflozin) tablets Prescribing Information Consumer site Health care professional site [H3] FASENRA® (benralizumab) injection, for subcutaneous use Prescribing Information Consumer site Health care professional site [H3] FASLODEX® (fulvestrant) injection, for intramuscular use Prescribing Information [H3] FLUMIST® (Influenza Vaccine Live, Intranasal) Prescribing Information Consumer site Health care professional site [H3] IMFINZI® (durvalumab) injection, for intravenous use Prescribing Information Consumer website Health care professional website [H3] IRESSA® (gefitinib) Prescribing Information [H3] KOMBIGLYZE® XR (saxagliptin and metformin HCl extended-release) tablets Prescribing Information including Boxed WARNING [H3] LOKELMA® (sodium zirconium cyclosilicate) 10 g for oral suspension Prescribing Information Consumer site Health care professional site [H3] LYNPARZA® (olaparib) tablets Prescribing Information Consumer site Health care professional site [H3] NEXIUM® (esomeprazole magnesium) delayed-release capsules, for oral suspension Prescribing Information Consumer site Health care professional site [H3] NEXIUM® (esomeprazole magnesium) for delayed-release oral suspension Prescribing Information Consumer site Health care professional site [H3] NEXIUM® I.V. (esomeprazole sodium) for injection, for intravenous use Prescribing Information [H3] ONGLYZA® (saxagliptin) tablets Prescribing Information [H3] PULMICORT RESPULES® (budesonide inhalation suspension) Prescribing Information [H3] QTERN® (dapagliflozin and saxagliptin) tablets Prescribing Information [H3] SAPHNELO® (anifrolumab-fnia) Injection, for intravenous use Prescribing Information Consumer site Health care professional site [H3] SEROQUEL® (quetiapine) tablets Prescribing Information including Boxed WARNINGS [H3] SEROQUEL XR® (quetiapine) Extended-release tablets Prescribing Information including Boxed WARNINGS Consumer site Health care professional site [H3] SYMBICORT® (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol Prescribing Information Consumer site Health care professional site [H3] SYMLIN® (pramlintide acetate) injection Prescribing Information including Boxed WARNING [H3] TAGRISSO® (osimertinib) tablets Prescribing Information Consumer site Health care professional site [H3] TEZSPIRE® (tezepelumab-ekko) Injection, for subcutaneous use Prescribing Information Consumer site Health care professional site [H3] TRUQAP™ (capivasertib) Prescribing Information Consumer site Health care professional site [H3] WAINUA™ (eplontersen) Prescribing Information [H3] XIGDUO® XR (dapagliflozin and metformin HCl extended-release) tablets Prescribing Information including Boxed WARNING
SUB-PAGE (https://onglyza.com/medicines/Affordability.html) AstraZeneca Medications
[H2] The list below contains full Prescribing Information for all of our medicines and a range of websites dedicated to providing you with product-specific information. The information contained below is intended for US residents only. In order to monitor the safety of AstraZeneca products, we encourage reporting any side effects experienced while taking an AstraZeneca product to the AZ Information Center at 1-800-236-9933. Alternatively, you can report any side effects of prescription drugs directly to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088. [H2] Help affording your medicines We believe it’s not enough for us to simply make medicines. We have to make sure that the people who need those medicines can get them. Learn more [H3] AIRSUPRA™ (albuterol/budesonide) Prescribing Information Consumer site Health care professional site [H3] ANDEXXA® Coagulation Factor Xa (recombinant), inactivated-zhzo Prescribing Information Consumer site Health care professional site [H3] BAXFENDY® (baxdrostat) Tablets Prescribing Information Consumer site Health care professional site [H3] BEVESPI AEROSPHERE® (glycopyrrolate and formoterol fumarate) Inhalation Aerosol Prescribing Information Consumer site [H3] BREZTRI AEROSPHERE® (budesonide, glycopyrrolate, and formoterol fumarate) Inhalation Aerosol Prescribing Information Consumer site Health care professional site [H3] BRILINTA® (ticagrelor) tablets Prescribing Information including Boxed WARNINGS Consumer site Health care professional site [H3] BYDUREON BCise® (exenatide extended-release) injectable suspension Prescribing Information including Boxed WARNING [H3] BYETTA® (exenatide) injection Prescribing Information [H3] CALQUENCE® (acalabrutinib) tablets Prescribing Information Consumer site Health care professional site [H3] CRESTOR® (rosuvastatin) Tablets Prescribing Information Consumer site Health care professional site [H3] DALIRESP® (roflumilast) tablets Prescribing Information Consumer site Health care professional site [H3] ENHERTU® (fam-trastuzumab deruxtecan-nxki) injection for intravenous use Prescribing Information including Boxed WARNING Health care professional site [H3] EPANOVA® (omega-3-carboxylic acids) Capsules Prescribing Information [H3] FARXIGA® (dapagliflozin) tablets Prescribing Information Consumer site Health care professional site [H3] FASENRA® (benralizumab) injection, for subcutaneous use Prescribing Information Consumer site Health care professional site [H3] FASLODEX® (fulvestrant) injection, for intramuscular use Prescribing Information [H3] FLUMIST® (Influenza Vaccine Live, Intranasal) Prescribing Information Consumer site Health care professional site [H3] IMFINZI® (durvalumab) injection, for intravenous use Prescribing Information Consumer website Health care professional website [H3] IRESSA® (gefitinib) Prescribing Information [H3] KOMBIGLYZE® XR (saxagliptin and metformin HCl extended-release) tablets Prescribing Information including Boxed WARNING [H3] LOKELMA® (sodium zirconium cyclosilicate) 10 g for oral suspension Prescribing Information Consumer site Health care professional site [H3] LYNPARZA® (olaparib) tablets Prescribing Information Consumer site Health care professional site [H3] NEXIUM® (esomeprazole magnesium) delayed-release capsules, for oral suspension Prescribing Information Consumer site Health care professional site [H3] NEXIUM® (esomeprazole magnesium) for delayed-release oral suspension Prescribing Information Consumer site Health care professional site [H3] NEXIUM® I.V. (esomeprazole sodium) for injection, for intravenous use Prescribing Information [H3] ONGLYZA® (saxagliptin) tablets Prescribing Information [H3] PULMICORT RESPULES® (budesonide inhalation suspension) Prescribing Information [H3] QTERN® (dapagliflozin and saxagliptin) tablets Prescribing Information [H3] SAPHNELO® (anifrolumab-fnia) Injection, for intravenous use Prescribing Information Consumer site Health care professional site [H3] SEROQUEL® (quetiapine) tablets Prescribing Information including Boxed WARNINGS [H3] SEROQUEL XR® (quetiapine) Extended-release tablets Prescribing Information including Boxed WARNINGS Consumer site Health care professional site [H3] SYMBICORT® (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol Prescribing Information Consumer site Health care professional site [H3] SYMLIN® (pramlintide acetate) injection Prescribing Information including Boxed WARNING [H3] TAGRISSO® (osimertinib) tablets Prescribing Information Consumer site Health care professional site [H3] TEZSPIRE® (tezepelumab-ekko) Injection, for subcutaneous use Prescribing Information Consumer site Health care professional site [H3] TRUQAP™ (capivasertib) Prescribing Information Consumer site Health care professional site [H3] WAINUA™ (eplontersen) Prescribing Information [H3] XIGDUO® XR (dapagliflozin and metformin HCl extended-release) tablets Prescribing Information including Boxed WARNING
SUB-PAGE (https://onglyza.com/az-in-us.html) AstraZeneca Medications
[H2] The list below contains full Prescribing Information for all of our medicines and a range of websites dedicated to providing you with product-specific information. The information contained below is intended for US residents only. In order to monitor the safety of AstraZeneca products, we encourage reporting any side effects experienced while taking an AstraZeneca product to the AZ Information Center at 1-800-236-9933. Alternatively, you can report any side effects of prescription drugs directly to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088. [H2] Help affording your medicines We believe it’s not enough for us to simply make medicines. We have to make sure that the people who need those medicines can get them. Learn more [H3] AIRSUPRA™ (albuterol/budesonide) Prescribing Information Consumer site Health care professional site [H3] ANDEXXA® Coagulation Factor Xa (recombinant), inactivated-zhzo Prescribing Information Consumer site Health care professional site [H3] BAXFENDY® (baxdrostat) Tablets Prescribing Information Consumer site Health care professional site [H3] BEVESPI AEROSPHERE® (glycopyrrolate and formoterol fumarate) Inhalation Aerosol Prescribing Information Consumer site [H3] BREZTRI AEROSPHERE® (budesonide, glycopyrrolate, and formoterol fumarate) Inhalation Aerosol Prescribing Information Consumer site Health care professional site [H3] BRILINTA® (ticagrelor) tablets Prescribing Information including Boxed WARNINGS Consumer site Health care professional site [H3] BYDUREON BCise® (exenatide extended-release) injectable suspension Prescribing Information including Boxed WARNING [H3] BYETTA® (exenatide) injection Prescribing Information [H3] CALQUENCE® (acalabrutinib) tablets Prescribing Information Consumer site Health care professional site [H3] CRESTOR® (rosuvastatin) Tablets Prescribing Information Consumer site Health care professional site [H3] DALIRESP® (roflumilast) tablets Prescribing Information Consumer site Health care professional site [H3] ENHERTU® (fam-trastuzumab deruxtecan-nxki) injection for intravenous use Prescribing Information including Boxed WARNING Health care professional site [H3] EPANOVA® (omega-3-carboxylic acids) Capsules Prescribing Information [H3] FARXIGA® (dapagliflozin) tablets Prescribing Information Consumer site Health care professional site [H3] FASENRA® (benralizumab) injection, for subcutaneous use Prescribing Information Consumer site Health care professional site [H3] FASLODEX® (fulvestrant) injection, for intramuscular use Prescribing Information [H3] FLUMIST® (Influenza Vaccine Live, Intranasal) Prescribing Information Consumer site Health care professional site [H3] IMFINZI® (durvalumab) injection, for intravenous use Prescribing Information Consumer website Health care professional website [H3] IRESSA® (gefitinib) Prescribing Information [H3] KOMBIGLYZE® XR (saxagliptin and metformin HCl extended-release) tablets Prescribing Information including Boxed WARNING [H3] LOKELMA® (sodium zirconium cyclosilicate) 10 g for oral suspension Prescribing Information Consumer site Health care professional site [H3] LYNPARZA® (olaparib) tablets Prescribing Information Consumer site Health care professional site [H3] NEXIUM® (esomeprazole magnesium) delayed-release capsules, for oral suspension Prescribing Information Consumer site Health care professional site [H3] NEXIUM® (esomeprazole magnesium) for delayed-release oral suspension Prescribing Information Consumer site Health care professional site [H3] NEXIUM® I.V. (esomeprazole sodium) for injection, for intravenous use Prescribing Information [H3] ONGLYZA® (saxagliptin) tablets Prescribing Information [H3] PULMICORT RESPULES® (budesonide inhalation suspension) Prescribing Information [H3] QTERN® (dapagliflozin and saxagliptin) tablets Prescribing Information [H3] SAPHNELO® (anifrolumab-fnia) Injection, for intravenous use Prescribing Information Consumer site Health care professional site [H3] SEROQUEL® (quetiapine) tablets Prescribing Information including Boxed WARNINGS [H3] SEROQUEL XR® (quetiapine) Extended-release tablets Prescribing Information including Boxed WARNINGS Consumer site Health care professional site [H3] SYMBICORT® (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol Prescribing Information Consumer site Health care professional site [H3] SYMLIN® (pramlintide acetate) injection Prescribing Information including Boxed WARNING [H3] TAGRISSO® (osimertinib) tablets Prescribing Information Consumer site Health care professional site [H3] TEZSPIRE® (tezepelumab-ekko) Injection, for subcutaneous use Prescribing Information Consumer site Health care professional site [H3] TRUQAP™ (capivasertib) Prescribing Information Consumer site Health care professional site [H3] WAINUA™ (eplontersen) Prescribing Information [H3] XIGDUO® XR (dapagliflozin and metformin HCl extended-release) tablets Prescribing Information including Boxed WARNING
SUB-PAGE (https://onglyza.com/medicines/astrazeneca-medications.html) AstraZeneca Medications
[H2] The list below contains full Prescribing Information for all of our medicines and a range of websites dedicated to providing you with product-specific information. The information contained below is intended for US residents only. In order to monitor the safety of AstraZeneca products, we encourage reporting any side effects experienced while taking an AstraZeneca product to the AZ Information Center at 1-800-236-9933. Alternatively, you can report any side effects of prescription drugs directly to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088. [H2] Help affording your medicines We believe it’s not enough for us to simply make medicines. We have to make sure that the people who need those medicines can get them. Learn more [H3] AIRSUPRA™ (albuterol/budesonide) Prescribing Information Consumer site Health care professional site [H3] ANDEXXA® Coagulation Factor Xa (recombinant), inactivated-zhzo Prescribing Information Consumer site Health care professional site [H3] BAXFENDY® (baxdrostat) Tablets Prescribing Information Consumer site Health care professional site [H3] BEVESPI AEROSPHERE® (glycopyrrolate and formoterol fumarate) Inhalation Aerosol Prescribing Information Consumer site [H3] BREZTRI AEROSPHERE® (budesonide, glycopyrrolate, and formoterol fumarate) Inhalation Aerosol Prescribing Information Consumer site Health care professional site [H3] BRILINTA® (ticagrelor) tablets Prescribing Information including Boxed WARNINGS Consumer site Health care professional site [H3] BYDUREON BCise® (exenatide extended-release) injectable suspension Prescribing Information including Boxed WARNING [H3] BYETTA® (exenatide) injection Prescribing Information [H3] CALQUENCE® (acalabrutinib) tablets Prescribing Information Consumer site Health care professional site [H3] CRESTOR® (rosuvastatin) Tablets Prescribing Information Consumer site Health care professional site [H3] DALIRESP® (roflumilast) tablets Prescribing Information Consumer site Health care professional site [H3] ENHERTU® (fam-trastuzumab deruxtecan-nxki) injection for intravenous use Prescribing Information including Boxed WARNING Health care professional site [H3] EPANOVA® (omega-3-carboxylic acids) Capsules Prescribing Information [H3] FARXIGA® (dapagliflozin) tablets Prescribing Information Consumer site Health care professional site [H3] FASENRA® (benralizumab) injection, for subcutaneous use Prescribing Information Consumer site Health care professional site [H3] FASLODEX® (fulvestrant) injection, for intramuscular use Prescribing Information [H3] FLUMIST® (Influenza Vaccine Live, Intranasal) Prescribing Information Consumer site Health care professional site [H3] IMFINZI® (durvalumab) injection, for intravenous use Prescribing Information Consumer website Health care professional website [H3] IRESSA® (gefitinib) Prescribing Information [H3] KOMBIGLYZE® XR (saxagliptin and metformin HCl extended-release) tablets Prescribing Information including Boxed WARNING [H3] LOKELMA® (sodium zirconium cyclosilicate) 10 g for oral suspension Prescribing Information Consumer site Health care professional site [H3] LYNPARZA® (olaparib) tablets Prescribing Information Consumer site Health care professional site [H3] NEXIUM® (esomeprazole magnesium) delayed-release capsules, for oral suspension Prescribing Information Consumer site Health care professional site [H3] NEXIUM® (esomeprazole magnesium) for delayed-release oral suspension Prescribing Information Consumer site Health care professional site [H3] NEXIUM® I.V. (esomeprazole sodium) for injection, for intravenous use Prescribing Information [H3] ONGLYZA® (saxagliptin) tablets Prescribing Information [H3] PULMICORT RESPULES® (budesonide inhalation suspension) Prescribing Information [H3] QTERN® (dapagliflozin and saxagliptin) tablets Prescribing Information [H3] SAPHNELO® (anifrolumab-fnia) Injection, for intravenous use Prescribing Information Consumer site Health care professional site [H3] SEROQUEL® (quetiapine) tablets Prescribing Information including Boxed WARNINGS [H3] SEROQUEL XR® (quetiapine) Extended-release tablets Prescribing Information including Boxed WARNINGS Consumer site Health care professional site [H3] SYMBICORT® (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol Prescribing Information Consumer site Health care professional site [H3] SYMLIN® (pramlintide acetate) injection Prescribing Information including Boxed WARNING [H3] TAGRISSO® (osimertinib) tablets Prescribing Information Consumer site Health care professional site [H3] TEZSPIRE® (tezepelumab-ekko) Injection, for subcutaneous use Prescribing Information Consumer site Health care professional site [H3] TRUQAP™ (capivasertib) Prescribing Information Consumer site Health care professional site [H3] WAINUA™ (eplontersen) Prescribing Information [H3] XIGDUO® XR (dapagliflozin and metformin HCl extended-release) tablets Prescribing Information including Boxed WARNING
This page presents a snapshot of public data from AstraZeneca, captured on May 31, 2026, to show how machine logic reads Semantic Coherence signals into an AI reputation evaluation.
Purpose: This data is presented under “Fair Use” for the purpose of independent signal analysis, allowing readers to see the raw signals behind the reputation score.
Notice to AstraZeneca: This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results are intended as professional feedback to help improve any website’s machine-readability and authority signals. The evaluation is free, and any company can request a fresh audit at any time.
Any company can use the insights for free and improve its voice. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://onglyza.com to view the most current version of its content and see directly what this company is about and what it offers.